(Georgetown University Medical Center) Researchers exploring why some women who take a common breast cancer drug develop serious joint pain have eliminated two possible causes: Inflammatory arthritis and autoimmune disease.
Because of these findings, researchers say women should be encouraged to continue taking the medication to gain its full benefit.
breast cancer drugStudy helps eliminate causes for joint pain linked to commonly u...EurekAlert! - Cancer Thu, 11/10/2011 - 23:00
Tags:
Joint Pain Linked To Breast Cancer Drug Not Inflammatory Arthrit...Medical News Today Tue, 11/09/2010 - 06:00
A new study suggests joint complaints attributed to aromatase inhibitors (AI), popular breast cancer drugs, are not associated with inflammatory arthritis or autoimmune disease. Tags:
FDA delays decision on breast cancer drug AvastinHeadlines from the Associated Press Fri, 09/17/2010 - 16:32
WASHINGTON (AP) -- Drugmaker Roche said Friday that U.S. health regulators will take more time to review its drug Avastin for breast cancer, a use that has generated vigorous debate among cancer specialists and patients.... FDA delays decision on breast cancer drug Avastinwashingtonpost.com - Health Fri, 09/17/2010 - 16:32
WASHINGTON -- Drugmaker Roche said Friday that U.S. health regulators will take more time to review its drug Avastin for breast cancer, a use that has generated vigorous debate among cancer specialists and patients. Tags:
FDA says breast cancer drug did not extend livesHeadlines from the Associated Press Fri, 07/16/2010 - 10:48
WASHINGTON (AP) -- Federal health scientists said Friday that follow-up studies of a Roche breast cancer drug show it failed to slow tumor growth or extend patient lives, opening the door for a potential withdrawal in that indication.... UK recommends against buying breast cancer drugHeadlines from the Associated Press Wed, 06/09/2010 - 17:09
LONDON (AP) -- Britain's health watchdog on Thursday recommended against buying a breast cancer drug for patients with advanced disease.... Way to 'boost' breast cancer drugBBC News | Health | World Edition Tue, 02/23/2010 - 11:57
Scientists say they have discovered why some women don't respond to breast cancer treatment, and it may be fixable. Low forms of cyclin E reduce breast cancer drug's effectivenessEurekAlert! - Cancer Mon, 02/08/2010 - 23:00
(University of Texas M. D. Anderson Cancer Center) Overexpression of low-molecular-weight (LMW-E) forms of the protein cyclin E renders the aromatase inhibitor letrozole ineffective among women with estrogen-receptor-positive (ER+) breast cancers, researchers from the University of Texas M. Tags:
|
